Lakefront Biotherapeutics NV current report, Q4 FY2021

Business Context and Reporting Period

This Form 6-K is filed by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in metadata) for the month of December 2021. The filing, dated December 6, 2021, incorporates by reference a press release issued on December 3, 2021 (Exhibit 99.1). The registrant is a foreign private issuer based in Mechelen, Belgium, filing under Form 20-F.

Key Financial Metrics

The provided filing text does not contain specific financial data. It serves as a cover document to incorporate a press release by reference. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text.

Material Changes

The filing text does not detail specific material changes or comparative period data. It references a press release from December 3, 2021, which likely contains the material event, but the content of that release is not included in the provided input.

Guidance, Outlook, and Risks

No guidance, outlook, management commentary, or specific risk factors are detailed in the provided text. The document states that the information in the attached press release is incorporated into various Registration Statements (Forms F-3 and S-8), but does not summarize the content of those statements or the press release itself.

Investor Verification Checklist

  • Verify the content of the press release dated December 3, 2021 (Exhibit 99.1), as the material event is described there rather than in this cover letter.
  • Confirm the correct registrant name is Galapagos NV, noting the discrepancy with the metadata provided.
  • Review the referenced Registration Statements (Forms F-3 and S-8) for updated financial context if the press release impacts capital structure.
  • Check for subsequent filings if the press release announced a transaction requiring further disclosure.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.